123I-labelled vasoactive intestinal peptide receptor scintigraphy in patients with colorectal cancer.

por Raderer, M., Kurtaran, A., Hejna, M., Vorbeck, F., Angelberger, P., Scheithauer, W., Virgolini, I.
Publicado 1998

Decreased hepatic function in patients with hepatoma or liver metastasis monitored by a hepatocyte specific galactosylated radioligand.

por Virgolini, I., Müller, C., Klepetko, W., Angelberger, P., Bergmann, H., O'Grady, J., Sinzinger, H.
Publicado 1990

Improved Quality of Life in Patients Treated with Peptide Radionuclides

por Traub-Weidinger, T, Raderer, M., Uffmann, M., Angelberger, P., Kurtaran, A., Leimer, M., Preitfellner, J., Dudczak, R., Virgolini, I.
Publicado 2011

Scintigraphic evaluation of functional hepatic mass in patients with advanced breast cancer.

por Virgolini, I., Kornek, G., Höbart, J., Li, S. R., Raolerer, M., Bergmann, H., Scheithauer, W., Pantev, T., Angelberger, P., Sinzinger, H.
Publicado 1993